Medpace Central Labs Expand Singapore Facility
As part of our continuous effort to enhance our laboratory capabilities and better serve our Sponsors, Medpace is proud to announce the expansion of our…
Chronic Kidney Disease & Its Impact on Clinical Development – Part 2
This post is the second of a three-part blog series. In Part 2, we take a look at the biomarkers for chronic kidney disease.
Ask an Expert: Understanding Regulation and Validation Processes for Biomarkers
We sat down with Christopher Daniels, Director, Clinical Laboratory Services at Medpace, to discuss regulations and standards for biomarkers, validation process for central labs, and…
Belgium Central Lab Expansion
As part of our efforts to expand laboratory services and capabilities, Medpace’s central lab in Belgium recently completed extensive expansions including a new modern laboratory…
4 Key Considerations for Designing Immuno-Oncology Trials
As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of…
The Current Biomarker Landscape in Immuno-Oncology
Dr. El Mustapha Bahassi, Associate Director of Clinical Laboratories at Medpace, highlights the biomarker landscape in immuno-oncology clinical research.
Imaging Biomarkers for Autoimmune Diseases
Medpace Imaging Core Lab has experience and expertise in autoimmune imaging using conventional and molecular imaging methods.
Exciting CNS Breakthroughs: Where the Promise Lies
In a recent PharmaVoice article "Brain Wave: Breakthroughs Bring New Hope to CNS", Dr. Rick Scheyer, Vice-President, Medical Affairs at Medpace, provides comment on the state of…
Medpace to Present New Biomarker Assay Validation Methods at AAPS PharmSci 360
This year at AAPS PharmSci 360, scientists from Medpace’s bioanalytical laboratory will be presenting two scientific posters regarding new methods for biomarker assay validation. Stop…
New Biomarker Assay Validations from Medpace’s Central Labs
With an already robust menu of validated assays, the increase in new biomarker assay validations speaks to the seamless service we provide to our Sponsors.